You have 9 free searches left this month | to do more

paclitaxel

Paclitaxel is a drug used to treat Breast Cancer, Ovarian Cancer, Lung Cancer, and other conditions. Paclitaxel is being actively studied in 536 studies and prior, has been studied in 879.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Fox Chase Cancer CenterZefen Xiao
Hoffmann-La RocheUniversity of Oklahoma Health Sciences CenterZhimin Shao
M.D. Anderson Cancer CenterWashington University School of MedicineH.W.M. van Laarhoven
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital, ChineseAMS
2022-03-17
Mar 17, 2022
C
Recruiting
  • Ovarian Cancer
  • +3 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
2022-03-07
Mar 7, 2022
U
Recruiting
  • Breast Cancer
  • Paclitaxel
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2022-02-01
Feb 1, 2022
U
Active, not recruiting
  • Breast Neoplasm Female
  • Paclitaxel
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2022-01-10
Jan 10, 2022
U
Active, not recruiting
  • Breast Cancer
  • +3 more
  • Including Dallas And Austin, Texas
    22 Sites
2021-12-03
Dec 3, 2021
W
Recruiting
  • Cutaneous Angiosarcoma
  • Paclitaxel
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-05-25
May 25, 2021
A
Active, not recruiting
  • Triple Negative Metastatic Breast Cancer
  • +3 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • +3 more
  • Brussels, Belgium
  • +2 more
2022-03-02
Mar 2, 2022
N
Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Bethesda, Maryland
    National Cancer Institute Developmental Therapeutics Clinic
2022-03-17
Mar 17, 2022
S
Recruiting
  • Stomach Neoplasms
  • +2 more
  • Paclitaxel
  • Seoul, Korea, Republic of
    Gastric cancer center, Seoul St. Mary's Hospital
2021-07-01
Jul 1, 2021
A
Active, not recruiting
  • Breast - Female
  • Male Breast Cancer
  • Charlotte, North Carolina
    Levine Cancer Institute
2021-12-14
Dec 14, 2021
D
Active, not recruiting
  • Advanced Gastric Cancer
  • Paclitaxel
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
2021-09-22
Sep 22, 2021
U
Active, not recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
    University of Illinois
2022-01-28
Jan 28, 2022
S
Recruiting
  • Solid Tumor
  • Stomach Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
2021-08-21
Aug 21, 2021
A
Active, not recruiting
  • Gastric Cancer
  • Anyang, Korea, Republic of
  • +13 more
2022-04-05
Apr 5, 2022
W
Active, not recruiting
  • Transitional Cell Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
2021-08-30
Aug 30, 2021
E
Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
2021-09-03
Sep 3, 2021
H
Active, not recruiting
  • Ovarian Cancer
  • Tampa, Florida
  • +2 more
2022-03-17
Mar 17, 2022
N
Active, not recruiting
  • Head and Neck Cancer
  • Singapore, Singapore
    National Cancer Centre - Singapore
2021-09-06
Sep 6, 2021
A
Active, not recruiting
  • Advanced Breast Cancer
  • Ribociclib (LEE011)
  • Paclitaxel
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-10-28
Oct 28, 2021
E
No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
2022-04-06
Apr 6, 2022
T
Completed
  • Solid Tumor, Adult
  • EOC202
  • Paclitaxel
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2022-03-30
Mar 30, 2022